Cargando…
Exploiting moderate hypoxia to benefit patients with brain disease: Molecular mechanisms and translational research in progress
Hypoxia is increasingly recognized as an important physiological driving force. A specific transcriptional program, induced by a decrease in oxygen (O(2)) availability, for example, inspiratory hypoxia at high altitude, allows cells to adapt to lower O(2) and limited energy metabolism. This transcri...
Autores principales: | Ehrenreich, Hannelore, Gassmann, Max, Poustka, Luise, Burtscher, Martin, Hammermann, Peter, Sirén, Anna-Leena, Nave, Klaus-Armin, Miskowiak, Kamilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7615021/ https://www.ncbi.nlm.nih.gov/pubmed/37671067 http://dx.doi.org/10.1002/nep3.15 |
Ejemplares similares
-
Phenotype-Based Genetic Association Studies (PGAS)—Towards Understanding the Contribution of Common Genetic Variants to Schizophrenia Subphenotypes
por: Ehrenreich, Hannelore, et al.
Publicado: (2014) -
Accumulated environmental risk in young refugees – A prospective evaluation
por: Begemann, Martin, et al.
Publicado: (2020) -
Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues
por: Begemann, Martin, et al.
Publicado: (2021) -
Hippocampal neurons respond to brain activity with functional hypoxia
por: Butt, Umer Javed, et al.
Publicado: (2021) -
Erythropoietin as candidate for supportive treatment of severe COVID-19
por: Ehrenreich, Hannelore, et al.
Publicado: (2020)